Abstract. Objective To comparison of the effect of caebetocin and ergonovine combination with oxytocin in Preventing Postpartum Hemorrhage. Methods:120 full term pregnant women in the China-Japan Union Hospital of Jilin University were selected as the subjects of this study from June 2015 to December 2017.It was divided into the observation group (Group A) and the control group (Group B)according to the random digital table method, with 60 pregnant women in each group. Record the general information of pregnant women, the amount of bleeding of parturients, 2 hours and 12 hours after delivery and the change of hemoglobin, the times of contraction, the systolic pressure, and the diastolic pressure. Result There was no statistically significant difference in the general data (age, gestational week, birth weight) between the two groups of parturients. The amount of bleeding, the change of hemoglobin and the number of uterine contraction in the observation group were significantly better than those in the control group, P<0.05. . There was no significant difference in systolic and diastolic pressure between the two groups, P>0.05. Conclusions: The effect of using carbetocin to prevent postpartum hemorrhage is more significant than ergonovine combination with oxytocin, and can guarantee the safety of mothers, improve maternal prognosis, it is worthy of clinical application.
Introduction
Postpartum hemorrhage mainly refers to the maternal whose the amount of bleeding within 24 hours after natural childbirth is not less than 500mL, while the amount of bleeding within 24 hours after cesarean section is not less than 1000mL. Postpartum hemorrhage is a serious complication in the period of childbirth, which is the first cause of maternal death in China [1] [2] .The incidence rate is about 2%~3% of the total number of childbirth, so it is particularly important to prevent postpartum hemorrhage [3] .For patients with vaginal delivery, the most frequent period of postpartum hemorrhage is postpartum 2 hours. For patients with vaginal delivery, the most frequent period of postpartum hemorrhage is postpartum 2 hours. The most common cause of bleeding is uterine atony. Effective contractions can prevent and reduce postpartum hemorrhage. It is the key to control and reduce the incidence and mortality of postpartum hemorrhage. At present the literature about the ergonovine combined with oxytocin and carbetocin in prevention of postpartum hemorrhage is not so much, so this experimental study is very important.
Materials and Methods

General Information
Review from June 2015 to December 2017, the vaginal delivery pregnant woman in our hospital were singleton term. The patients increased vaginal bleeding after childbirth, some symptoms are shown as soft texture and unclear outline of the uterus. At the same time, the patients with placenta and fetal membrane residual, soft birth canal laceration, abnormal coagulation function, no drug application counterindication and so on were excluded. It was divided into the observation group (Group A) and the control group (Group B) according to the random digital table method, with 60 pregnant women in each group. The observation group aged 23 to 31(27.97±1.06) years old, the gestational weeks was 39 to 42 (40.01 ± 0.22), among them, there were 28 cases of primiparas and 32 cases of multiparas. The control group aged 24 to 33(28.54±1.12) years old, the gestational weeks was 39 to 42 (40.06±0.19), among them, there were 26 cases of primiparas and 34 cases of multiparas. There was no statistically significant difference in the general data such as age, gestational week, birth weight between the two groups of parturients (P>0.05). 
Methods
The observation group: patients used carbetocin to prevent postpartum hemorrhage, took intramuscular injection after removal of placenta, the dose was 100ug.The control group: patients used ergometrine combined with oxytocin to prevent postpartum hemorrhage, also took intramuscular injection after removal of placenta, the dose was 0.2mg for ergonovine and 5IU for oxytocin. In the process of birth, a series of life indicators should be closely monitored, and the corresponding treatment should be taken immediately if there was a bad situation.
Outcome Measures
(1) volume of bleeding: volume method and weight method were used to calculate the amount of vaginal bleeding. The two groups were recorded the amount of vaginal bleeding during delivery and postpartum after 2h and 24h, respectively.(2) Vital signs: the changes of blood pressure and heart rate were recorded in two groups of patients before the injection and 0.5 h and 2h after injection.(3) Side effects: recorded the side effects of two groups in 24 h after baby birth.(4) blood routine indicators: two groups took routine blood routine examination at first day, recorded the changes of red blood cell (RBC) and hemoglobin (Hb).
Obvious effect: the vaginal bleeding decreased obviously in 15min after injection, and the texture of the uterus was obviously hardened. Effective: the vaginal bleeding decreased in 30min after injection, and the texture of the uterus was hardened. Invalid: vaginal bleeding had not been reduced, uterine contraction was not good.
Side effects included headache, chest tightness, tinnitus, dyspnea, vomiting, diarrhea, allergies, and high blood pressure.
Statistical Methods
All data using SPSS 21.0 statistical software for processing, measurement data using mean and standard deviation (X±S) to represent. And paired t test for data comparation between two groups, P <0.05 considered statistically significant.
Result
Comparison of Therapeutic Effect
The total effective rate of the two groups was 100%, and no invalid patients were found. There was a statistically significant difference between two groups in the amount of postpartum hemorrhage and the decrease of blood routine index (P < 0.05). 
Comparison of Systolic Pressure and Diastolic Pressure Improvement in Two Groups
After injection, the systolic pressure and diastolic pressure of the group A and group B were significantly improved, but the difference between the two groups was relatively small, P>0.05,and no statistical significance. 
Comparison of Side Effects in Two Groups
Among the patients, there were one case of side effect in group A and one case in group B. The group B patient elevated blood pressure accompanied by headache symptoms, Patients took labetalol hydrochloride 100 mg and Magnesium Sulfate 5g , The blood pressure dropped to normal after 2 hours , observation to postpartum 24 h without recurrence, and we were not found the patient and neonatal convulsions, unconsciousness, convulsions, breathing difficulties and other symptoms like ergot poisoning. There is a slight side effect in patient of group that could be relieved without intervention.
Discussion
Postpartum hemorrhage is a worldwide problem. It is one of the leading causes of maternal death. With the implementation of the second child policy in China, the number of deliveries is increasing and the incidence of postpartum hemorrhage is increasing. In the four major causes of postpartum hemorrhage, uterine atony took the first place, accounting for about 70% to 80% [5] .Therefore, effective uterine contraction agent is the key to reduce postpartum hemorrhage, the complications of patients and improve the quality of obstetrics. To prevent of postpartum hemorrhage, oxytocin is internationally recognized as the first-line drug, but when oxytocin cannot reduce vaginal bleeding, others should be used [6] . However, the international and domestic guidelines do not have a clear and unified sequence on using of other oxytocins, so applications around the world are different.
Oxytocin is the drug that most commonly used for uterine contraction. The drug needs to be stored in cold storage and is a synthetic peptide hormone. The mechanism of it is to selectively promote the contraction of smooth muscle in uterine and mammary duct. The mechanism of exogenous oxytocin and endogenous oxytocin is the same, but the effect of exogenous is several times stronger than that of endogenous. Oxytocin played a role through the combination with oxytocin receptor. With the increase of gestational week, the receptors of oxytocin increased gradually, the uterus was more sensitive to oxytocin, and the concentration of receptors decreased according to the uterus, the lower segment of uterus and the cervix, that is, oxytocin mainly played a role in uterine body. A small doze of drug could make tension of the uterus smooth muscle increased ,uterine contractility strengthening, but can still maintain the rhythm, symmetry and polarity; While dose increases, it will lead to muscle tension increased, and incomplete relaxation, finally occurred tetanic contraction.
Ergonovine is commonly used in uterine contraction, but also the earliest oxytocin in the history [7] . Ergonovine is sensitive to light and heat, so it should be avoid light and preserve at less than 8℃. Ergonovine can directly effect on uterine smooth muscle, the effect is strong and durable, large doses can cause contraction of ankylosing uterine body and cervix ,even lower uterine segment. Patients with Chronic hypertension, hypertensive disorder, heart disease, liver and kidney function damage are unsuitable to such drugs [8] .The new preparation named Syntometrine (ergometrine-oxytocin) is a mixture of oxytocin and ergometrine, theoretically, the drug has a rapid onset and long duration of action. Effect of oxytocin on mild diastolic blood vessel ease the vasoconstrictive effect of ergonovine induced [9] .
Carbetocin is a synthetic peptide hormone which is considered to be a long-acting oxytocin. It combines with oxytocin receptor in uterine smooth muscle, can affect the rhythm and intensity of uterine muscle. Carbetocin is considered can be used to prevent postpartum hemorrhage, even some of the hospital applicate it in the third stage of labor in the routine to prevent postpartum hemorrhage. But also a study suggests that using carbetocin in cesarean section can reduce the amount of bleeding volumes in postpartum hemorrhage. The results of this study show that after application of ergonovine combined with oxytocin, hemoglobin concentration was decreased more significantly than that of carbetocin. It is suggested that the carbetocin is much more effective in preventing of postpartum hemorrhage. Ngan [10] also proved this.
Askar, et al [11] . found caebetocin cause nausea and vomiting with low incidence and other side effects such as facial flushing, headache, abdominal pain. Leung, et al [12] . Found that the caebetocin cause nausea and vomiting in lower incidence rather than ergonovine.
In conclusion, using carbetocin to prevent postpartum hemorrhage, the effect is more significant in reducing the amount of bleeding, also it can guarantee the maternal body balance, so that it can quickly return to normal life, it is worthy of clinical application.
